The effect of germline DNA repair mutations on radiosensitivity in pancreatic ductal adenocarcinoma.

被引:0
|
作者
Bryant, John Michael [1 ]
Peterson, John [1 ]
Park, Margaret [2 ]
Hodul, Pamela Joy [3 ]
Malafa, Mokenge Peter [3 ]
Denbo, Jason [3 ]
Kim, Dae Won [2 ]
Biachi de Castria, Tiago [4 ]
Fleming, Jason B. [2 ]
Oliver, Daniel Eli [2 ]
Grass, G. Daniel [1 ]
Frakes, Jessica M. [1 ]
Torres-Roca, Javier [2 ]
Hoffe, Sarah E. [1 ]
Palm, Russell F. [1 ]
机构
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Surg Oncol, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa Bay, FL, Uruguay
关键词
3282-206-2497; 261-492-3532-2370-7650-2700; 261-137; 261-566-148-11298; 283-237-267-6887-6888; 3282-206-4957-326-2356; 5; 4; 3; 2; 176; 1; 38092-33482; 38092-29727; 38092-27331; 38092-27327; 38092-27058; 38092-18853; 38092-18852; 38092-18780; 38092-18438;
D O I
10.1200/JCO.2024.42.3_suppl.703
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:703 / 703
页数:1
相关论文
共 50 条
  • [31] The germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma (vol 19, 301, 2021)
    Shui, Lin
    Li, Xiaofen
    Peng, Yang
    Tian, Jiangfang
    Li, Shuangshuang
    He, Du
    Li, Ang
    Tian, Bole
    Li, Mao
    Gao, Heli
    An, Ning
    Yi, Cheng
    Cao, Dan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [32] ATM as a biomarker for DNA damage repair deficiency in pancreatic ductal adenocarcinoma
    Golan, Talia
    Halparin, Sharon
    Stossel, Chani
    Raitses-Gurevich, Maria
    Atias, Dikla
    Buzhor, Ella
    Cohen, Keren
    Borshtein, Roni
    Schvimer, Michael
    Berger, Raanan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [33] Intratumoral fibrin as a novel immunomodulatory factor in pancreatic ductal adenocarcinoma.
    Wahab, Riajul
    Karim, Mazharul
    Hassan, Md Mahedi
    Grippo, Paul
    Bisheshari, Faraz
    Al-Hilal, Taslim
    CANCER RESEARCH, 2022, 82 (22) : 116 - 117
  • [34] Evaluation of putative prognostic tissue biomarkers in pancreatic ductal adenocarcinoma.
    Winter, J. M.
    Tang, L. H.
    Klimstra, D. S.
    Brennan, M. F.
    O'Reilly, E. M.
    Jarnagin, W. R.
    Allen, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [35] The tumor immune microenvironment is decisive in the survival of pancreatic ductal adenocarcinoma.
    Aziz, Hosein M.
    Saida, Lawlaw
    de Koning, Willem
    Stubbs, Andrew
    Li, Yunlei
    van Eijck, Casper H. J.
    Mustafa, Dana A. M.
    CANCER RESEARCH, 2021, 81 (22) : 80 - 81
  • [36] Oncogenic roles of CEACAM6 in pancreatic ductal adenocarcinoma.
    Mahadevan, Daruka
    Pandey, Ritu
    Chen, Yuliang
    Essif, Jacob
    Al-Khinji, Aisha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] NAMPT expression in stage I/II pancreatic ductal adenocarcinoma.
    Davis, Katelynn
    Dunseth, Craig
    Mott, Sarah L.
    Bellizzi, Andrew
    Chan, Carlos Hou Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] The role of p53 in the development of pancreatic ductal adenocarcinoma.
    Hanson, Kathryn J.
    Flowers, Brittany M.
    Hughes, Nicholas
    Vogel, Hannes
    Cong, Le
    Attardi, Laura D.
    CANCER RESEARCH, 2021, 81 (22) : 58 - 58
  • [39] The role of whole genome duplication in progression of pancreatic ductal adenocarcinoma.
    Hummel, Lauren
    Xie, Irene
    Ng, Karen
    Zhang, Amy
    Ramotar, Stephanie
    Dodd, Anna
    O'Kane, Grainne
    Knox, Jennifer
    Wilson, Julie
    Gallinger, Steven
    Notta, Faiyaz
    CANCER RESEARCH, 2022, 82 (22) : 81 - 81
  • [40] Prognostic influence of waiting time in management of pancreatic ductal adenocarcinoma.
    Suzuki, Rei
    Takagi, Tadayuki
    Hikichi, Takuto
    Ohira, Hiromasa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35